Top Markets
#1 Audiera Audiera +34.54%
#2 GALA GALA +33.70%
#3 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +32.94%
#4 Bitcoin Cash Bitcoin Cash +32.85%
#5 Fabric Protocol Fabric Protocol +32.18%
#6 Tutorial Tutorial +31.23%
#7 Arowana Arowana +28.17%
#8 Zora Zora +27.86%
#9 B3 (Base) B3 (Base) +27.09%
#10 Pepe Pepe +26.40%
Coin of the day
Audiera Audiera
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Rang in Aktien #24577
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Aktienkurs
$1.48
Zuletzt synchronisiert: 2025-03-24
Marktkapitalisierung
$59.05M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Achilles Therapeutics plc (ACHL)

Kategorie

Healthcare
Kursverlauf für Achilles Therapeutics plc (ACHL)
Höchster Schlusskurs: $1.42 am 2025-03-01

Niedrigster Schlusskurs: $16.55 am 2021-03-01
Kursverlauf der Aktie von Achilles Therapeutics plc von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 35.96%
2024 21.05%
2023 -23.13%
2022 -77.06%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.38 37.72%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 58.85%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -18.24%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.47 435.74%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 9.84%
CH